Rewriting the health playbook: How Abu Dhabi is scaling AI and digital care
In April 2025, global health leaders, policymakers, innovators, and researchers convened for Abu Dhabi Global Health Week (ADGHW)—a flagship initiative of the Department of Health – Abu Dhabi (DoH). Held under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, the year-round global platform advances transformative solutions across health and life sciences. Health doesn't operate in a silo; it calls for critical thinking and collaboration among practitioners, policymakers, pharmaceutical leaders, researchers, and frontline healthcare workers accelerating shared health ambitions worldwide.
The 2025 theme, 'Towards Longevity: Redefining Health and Well-being,' mirrors ADGHW's ambition: shifting from episodic treatment to continuous, preventive, and personalised care.
The promise of digital health and AI
One pressing theme that has dominated the public health discourse in the past few years is digital health and artificial intelligence (AI). Advanced technologies are unlocking new frontiers by improving access, enhancing clinical outcomes, and supporting more resilient health systems. From remote monitoring, AI-diagnostics, to telemedicine and predictive analysis, Abu Dhabi is reimagining care pathways to deliver personalised treatment while empowering providers with real-time, data-driven insights.
ET Spotlight
H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi
According to H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, 'Digital health allows us to tailor care to the needs of each individual while improving access across diverse communities. Whether through telemedicine platforms or data-enabled prevention strategies, our focus is on strengthening system resilience and enhancing patient outcomes.'
Abu Dhabi's growing trust-based health data and technical infrastructure presents a fertile ground for innovation. Initiatives such as Malaffi, the region's first Health Information Exchange, and the Emirati Genome Program are central to this vision. While the former facilitates real-time data sharing among care providers, the latter creates a unique dataset to analyse genetic predispositions to build better individual and population-level responses in health management.
Live Events
India's interest in scaling population health genomics (through initiatives such as the Genome India project, which aims to map the genetic diversity of the Indian population) aligns with such frameworks in Abu Dhabi. Data governance, ethical AI usage, and consent frameworks are some of the fronts where cross-border collaboration could be envisioned.
Innovation Through Strategic Initiatives
Initiatives announced at ADGHW 2025 reflect Abu Dhabi's role as a global health innovation leader, unveiling a suite of bold new initiatives that move digital health from concept to execution.
Notably, the launch of the Health, Endurance, Longevity, and Medicine (HELM) Cluster—a partnership between the Abu Dhabi Investment Office, Mohamed bin Zayed University of Artificial Intelligence, and Hub71—signals a bold step toward advancing health life sciences, R&D, and building a robust ecosystem for medical innovation, pharmaceutical manufacturing, and biotechnology.
The Startup Zone and Smart Health Hackathon spotlighted emerging innovators tackling real-world health challenges through AI-powered and digital-first approaches. The inaugural ADGHW Innovation Awards were also introduced, recognising breakthroughs that are driving meaningful improvements in patient outcomes, healthcare accessibility, and system efficiency.
A human-centred approach to innovation
However, digital transformation in healthcare transcends the technological realm. It must be rooted in the realities of patients and on-ground experiences that have emerged from years of clinical practice. Dr. Asma Al Mannaei, Executive Director of the of the Health Life Sciences Sector at the Department of Health – Abu Dhabi, underscores its impact; 'The future of health is patient-centred. Technology is a powerful enabler, but the true impact comes when innovations align with human need.'
Technologies shown at ADGHW are shifting health towards proactive and predictive models of care, helping individuals manage chronic conditions, while algorithms interpret patient data to identify health risks before they escalate.
B
uilding a future-ready healthcare workforce
The success of this transformation depends equally on human capital. As AI and digital tools become more embedded in health workflows, there is a growing need for skilled professionals who can operate in hybrid, tech-enabled environments.
'Investing in workforce development is key to realising the benefits of digital health,' notes Dr. Rashed Obaid Al Suwaidi, Director General of the Abu Dhabi Public Health Centre (ADPHC) . 'Our role is to ensure that future clinicians and allied health professionals are equipped with both clinical and digital competencies, ensuring a seamless integration of innovation into care delivery.'
This is true in the context of India as well, as it seeks to upskill its healthcare workforce to adopt emerging technologies. Abu Dhabi's initiatives present a model for India's academic and public-private institutions. The focus is on supporting the development of an AI-trained workforce capable of advancing both diagnostic precision and operational efficiency.
Public health, equity, and global collaboration
ADGHW 2025 also steered conversations on policy innovation, to drive an actionable agenda across global collaborators. A major milestone was the launch of a Global Declaration on Longevity and Precision Health, outlining an actionable agenda to extend both lifespan and healthspan through international cooperation and innovation, placing longevity at the heart of global health priorities.
The Department of Health – Abu Dhabi (DoH) also signed a landmark Memorandum of Understanding (MoU), which focuses on advancing precision medicine and genomics in oncology, rare genetic disorders, and metabolic diseases, leveraging AI and collaborative research to pioneer new treatment pathways. This multi-stakeholder partnership included PureHealth, M42, Illumina, Khalifa University (KU), New York University Abu Dhabi (NYUAD), and the Institute for Healthier Living Abu Dhabi (IHLAD).
In a world-first, Abu Dhabi unveiled the AI-powered Population Health Intelligence Framework—a learning health system designed to continuously predict, prevent, and respond to public health challenges through AI and real-time analytics.
'Public health must be inclusive, data-informed, and anticipatory,' says H.E. Dr. Rached Obaid Al Suwaidi, Director-General of Abu Dhabi Public Health Center (ADPHC). 'Through ADGHW, we are advocating for integrated approaches that connect population health strategies with emerging digital tools.'
This intersection of innovation and inclusion is critical as healthcare systems globally face challenges of scale, access, and sustainability. Through these measures, Abu Dhabi is positioning itself as both a contributor and convener in shaping the global health agenda.
Infrastructure for impact
Technology alone does not deliver transformation, it must be embedded within systems designed for agility, interoperability, and scale. Ibrahim Al Jallaf, Division Director of Digital Health at DoH, underscores that 'Our focus is on integrating digital health tools into a unified ecosystem. Whether it's through regulatory frameworks, investment incentives, or data platforms, we are building the infrastructure to support sustained impact.'
ADGHW also provides the economic foundation for this transformation. By 2045, Abu Dhabi's life sciences sector is projected to contribute over AED 94 billion to GDP and generate more than 30,000 jobs. This economic vision is tightly interlinked with the health innovation agenda, making the Emirate a compelling hub for Indian health tech startups seeking Middle East expansion.
From Abu Dhabi to the world
As a year-round platform, ADGHW fosters a strategic bridge between global health priorities and local capacity, creating a space where data, expertise, and ambition converge.
For leaders across government, academia, industry, and civil society, it presents an opportunity to co-create solutions that resonate far beyond borders, enhancing health outcomes not only for individuals but for entire communities and nations.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Ways to rice water Using beyond cooking
Rice water, the starchy liquid left after soaking or boiling rice — is often discarded in kitchens. But this humble byproduct is a treasure trove of nutrients, packed with amino acids, vitamins, and minerals. Tired of too many ads? go ad free now Traditionally used in many Asian cultures for skincare, hair care, and even home remedies, rice water is making a modern comeback. Here are several ways you can use rice water beyond just cooking. As a Natural Hair Rinse Rice water is rich in inositol, a carbohydrate that strengthens hair, reduces friction, and adds shine. Use fermented rice water as a final hair rinse after shampooing. It helps reduce frizz, detangles hair, and may also promote growth. A study published in the International Journal of Cosmetic Science (2010) highlighted how inositol from rice water penetrates hair strands and repairs damage. For Glowing Skin Used as a toner or face mist, rice water can brighten the skin, tighten pores, and soothe inflammation. It contains antioxidants and starches that calm irritated skin and improve elasticity. Regular application can help reduce pigmentation and boost hydration, especially for sensitive or acne-prone skin. Natural Plant Fertilizer Rice water is an excellent natural fertilizer for plants. The leftover starch nourishes soil microbes and encourages root growth. Use diluted, unseasoned rice water to water plants once or twice a week. It's particularly beneficial for leafy greens and potted herbs. Digestive Health In traditional Indian and Asian medicine, rice water is consumed to soothe an upset stomach. It's light, hydrating, and can help manage diarrhea or mild dehydration. Tired of too many ads? go ad free now The starch content helps coat the stomach lining and improve digestion. Simply boil rice in extra water and strain out the liquid for use. Coolant in Summer Rice water is a natural coolant and is traditionally consumed in tropical regions during hot months. Add a pinch of salt and lemon to it for an instant homemade electrolyte drink. It helps prevent heatstroke, especially when consumed during peak summer afternoons. Homemade face packs Rice water can be added to gram flour, sandalwood, or multani mitti (Fuller's earth) to make skin-brightening face packs. It acts as a gentle base that enhances the pack's anti-inflammatory and tightening properties. Regular use can leave the skin smooth and radiant.
Time of India
2 hours ago
- Time of India
Narayana Hrudayalaya expands Bengaluru presence with Rs 246 cr land deal on Bannerghatta Road
Hospital network Narayana Health has acquired prime land parcels worth Rs 246 crore on Bannerghatta Main Road, a rapidly emerging healthcare corridor in Bengaluru, marking one of the most significant institutional healthcare real estate transactions of 2025. The acquisition, executed through three separate sale deeds dated February 3, 2025, was transacted with members of the same family—Thomas Markose, Neelu Markose and their partnership firm Kelachandra Veneer Industries—according to registration documents accessed via Propstack. The largest of the three transactions involved a payment of Rs 177.7 crore for land covering 93,500 sq ft, including approximately 10,000 sq ft of dilapidated built-up area. The sellers were Kelachandra Veneer Industries, represented by Thomas and Neelu Markose. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Join new Free to Play WWII MMO War Thunder War Thunder Play Now Undo Separately, 17,424 sq ft was purchased from Neelu Markose for Rs 33.1 crore, and another 18,513 sq ft was acquired from Thomas Markose for Rs 35.17 crore. In total, Narayana Health, earlier known as Narayana Hrudayalayay, now controls about 120,000 sq ft, or about 3 acres, in Hulimavu, a neighbourhood strategically located along one of the city's busiest medical zones, said the sales document. Live Events This purchase builds on Narayana Health's aggressive land acquisition strategy in the city. In March 2024, the hospital chain had acquired 1.2 acres of land for Rs 169 crore in Begur Hobli, also in southern Bengaluru, according to data from Propstack. That deal involved 52,272 sq ft purchased from Venture Projects Bangalore Private Limited. Founded by cardiac surgeon Dr. Devi Shetty in 2000, Narayana Health has established itself as a significant player in the Indian healthcare landscape, driven by its model of providing affordable, high-quality care. Narayana Health operates a network of approximately 19 hospitals and three heart centres across India, along with an overseas presence in the Cayman Islands. It boasts of over 5,860 operational beds and a capacity for over 6,160 beds across its facilities. Sources said the newly acquired land on Bannerghatta Road could be used to build a super-specialty unit, a healthcare training institute, or a medical research centre, as part of its long-term infrastructure expansion strategy. A senior healthcare consultant familiar with the deal said, 'This move reflects Narayana Hrudayalaya 's continued commitment to strengthening its presence in Bengaluru and scaling infrastructure to meet rising demand for super-specialty and research-oriented care.' Bannerghatta Road has evolved into a vital healthcare and residential corridor, with several leading hospitals, diagnostics labs and medical colleges already established. Infrastructure upgrades, including the expansion of metro connectivity, are boosting land value in the area. 'The Hulimavu acquisition not only offers strategic adjacency to existing Narayana Hrudayalaya operations but also positions the group for long-term growth amid increasing urban healthcare needs,' he said. Meanwhile, Bengaluru has seen a sharp rise in high-value land transactions, including notable residential and institutional asset purchases by prominent healthcare professionals such as Dr. Anesh Shetty and Dr. Devi Prasad Shetty of Narayana Health. The super-luxury residential and large land parcel segments are witnessing robust demand across major Indian metros. According to Knight Frank India, the number of ultra-high-net-worth individuals (UHNWIs) in India — defined as those with a net worth exceeding $30 million — is expected to grow by 58.4% in the next five years, reaching 19,119 by 2027, up from 12,069 in 2022. India's billionaire count is projected to increase from 161 in 2022 to 195 by 2027, fueling demand for prime real estate in the healthcare, residential, and institutional segments.
Mint
3 hours ago
- Mint
India boost to pharma & medtech R&D with ₹5,000 cr portal
New Delhi: The Department of Pharmaceuticals has launched an online portal for a ₹ 5,000-crore scheme it says will support innovation in pharma and medical technology. PRIP, or the Promotion of Research and Innovation in Pharma MedTech Sector, promises to make it easier to submit applications to develop novel technologies in medicine, including medical devices and drugs for communicable, non-communicable diseases and rare disease. The government is concerned about the tiny levels of domestic R&D spending, compared with many other nations, despite India being a global leader in generic drug production. While the US and China spend $60 billion and $20 billion on pharmaceutical R&D respectively, India's expenditure is only around $3 billion. PRIP aims to bridge this gap and foster a culture of research and innovation in the pharma and medtech industry. The scheme has two main components. First, strengthening research infrastructure: This involves setting up Centres of Excellence (CoEs) in the seven existing National Institutes of Pharmaceutical Education & Research (NIPERs). Second, Promoting Research in Pharma & MedTech: This component offers direct financial assistance to companies and projects for both in-house R&D and academic collaborations. It covers six priority areas, including drug discovery and development, medical devices, stem cell therapy, medicines for rare diseases and treatment for drug-resistant patients. "With the PRIP portal now live, the government is making it simple for pharma companies, medtech firms, and even startups to register and elevate their research and development capabilities," explained an official. As planned under the scheme, bigger companies can seek funding of up to ₹ 125 crore while startups can secure up to ₹ 1 crore over a period of five years, based on their milestones, the official said. India's pharmaceutical market is a global force, valued at $50 billion. While domestic consumption stands at $23.5 billion, exports contribute a significant $26.5 billion. India is the world's third-largest pharmaceutical market by volume and 14th by value of production. Over half its exports reach highly developed markets like the US, EU, and Japan, which have a high threshold on quality. Sheetal Arora, promoter and CEO of Mankind Pharma, emphasized the transformative potential of the PRIP scheme. "The new PRIP portal is a game-changer for Indian pharma. This ₹ 5,000-crore investment is exactly the boost we need as we're on the verge of massive growth. India already leads the world in generic medicines, providing 20% of the global supply. But PRIP helps us shift towards innovation, potentially bringing in another ₹ 17,000 crore for R&D by FY28. This will truly sharpen our competitive edge. The timing couldn't be better. With many major drugs losing patent protection by 2030, companies that invest in new molecules and top-tier research now will be future leaders. What's most exciting is that PRIP supports both innovation and affordable healthcare.' Arora added that PRIP supports both innovation and affordable healthcare. 'This perfectly fits India's goal of being a global innovation hub while also making medicines accessible worldwide. PRIP isn't just about money; it's about empowering Indian pharma to build a strong, self-reliant future where innovation benefits everyone,' she said.
